Research Topic · Peer-Reviewed

Complement Activation

Complement activation is the triggered, sequential operation of the complement system, a network of plasma and cell-surface proteins that forms a central effector arm of innate immunity. Activation proceeds through three converging routes, the classical, lectin, and alternative pathways, which differ in their initia…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 17× across the literature 🔖 ISSN 2689-5773 🗓 Reviewed July 2026

Overview

Complement activation is the triggered, sequential operation of the complement system, a network of plasma and cell-surface proteins that forms a central effector arm of innate immunity. Activation proceeds through three converging routes, the classical, lectin, and alternative pathways, which differ in their initiating recognition events: antibody-antigen complexes, the binding of mannose-binding lectin and related molecules to microbial carbohydrates, and the spontaneous, surface-regulated turnover of complement components. Each pathway converges on the cleavage of central components, generating opsonins that tag pathogens for phagocytosis, anaphylatoxins that promote inflammation and recruit immune cells, and the membrane attack complex that lyses susceptible targets. Tight regulation by inhibitory proteins normally restricts complement to appropriate surfaces, and dysregulated or excessive activation contributes to tissue injury and inflammatory and autoimmune disease, including the inflammatory processes implicated in arthritic joints and in severe infection. Lectin-pathway recognition of carbohydrate structures also links complement to host defense against viruses. The significance of complement activation spans infection, inflammation, autoimmunity, and immunopathology, informing both diagnosis and therapy. Sub-areas include the classical, lectin, and alternative pathways, opsonization, anaphylatoxin signaling, the membrane attack complex, complement regulation, and the role of complement in inflammatory and immune-mediated disease.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 5 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Complement Activation, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Clinical and Diagnostic Pathology (ISSN 2689-5773).

Journal editorial board
Pietro Scicchitano · Italy Wael M. EL-Deeb · Saudi Arabia Bulent Uysal · United States

This page summarises published research for orientation; it is not medical or professional advice.